首页> 美国卫生研究院文献>Cancers >Discoidin Domain Receptor-1 (DDR1) is Involved in Angiolymphatic Invasion in Oral Cancer
【2h】

Discoidin Domain Receptor-1 (DDR1) is Involved in Angiolymphatic Invasion in Oral Cancer

机译:Discoidin域受体1(DDR1)参与口腔癌的血管淋巴管浸润。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The discoidin domain receptor-1 (DDR1) is a non-integrin collagen receptor recently implicated in the collective cell migration of other cancer types. Previously, we identified an elevated expression of DDR1 in oral squamous cell carcinoma (OSCC) cells. Through the data mining of a microarray dataset composed of matched tumor-normal tissues from forty OSCC patients, we distilled overexpressed genes statistically associated with angiolymphatic invasion, including DDR1, COL4A5, COL4A6 and PDPN. Dual immunohistochemical staining further confirmed the spatial locations of DDR1 and PDPN in OSCC tissues indicative of collective cancer cell invasion. An elevated DDR1 expression at both the transcription and protein level was observed by treating keratinocytes with collagen of fibrillar or basement membrane types. In addition, inhibition of DDR1 kinase activity in OSCC TW2.6 cells disrupted cell cohesiveness in a 2D culture, reduced spheroid invasion in a collagen gel matrix, and suppressed angiolymphatic invasion in xenograft tissues. Taken together, these results suggest that collagen deposition in the affected tissues followed by DDR1 overexpression could be central to OSCC tumor growth and angiolymphatic invasion. Thus, DDR1 inhibitors are potential therapeutic compounds in restraining oral cancer, which has not been previously explored.
机译:Discoidin域受体1(DDR1)是非整合素胶原受体,最近与其他类型的癌症的集体细胞迁移有关。以前,我们发现口腔鳞状细胞癌(OSCC)细胞中DDR1的表达升高。通过对40例OSCC患者的匹配肿瘤正常组织组成的微阵列数据集进行数据挖掘,我们提取了与血管淋巴管浸润统计相关的过表达基因,包括DDR1,COL4A5,COL4A6和PDPN。双重免疫组织化学染色进一步证实了DDR1和PDPN在OSCC组织中的空间位置,表明了癌细胞的集体侵袭。通过用原纤维或基底膜类型的胶原蛋白处理角质形成细胞,可观察到在转录和蛋白水平上DDR1表达均升高。另外,OSCC TW2.6细胞中DDR1激酶活性的抑制破坏了2D培养物中的细胞内聚性,减少了胶原凝胶基质中的球状体入侵,并抑制了异种移植组织中的血管淋巴管入侵。两者合计,这些结果表明胶原蛋白沉积在受影响的组织中,然后DDR1过表达可能是OSCC肿瘤生长和血管淋巴管浸润的关键。因此,DDR1抑制剂是抑制口腔癌的潜在治疗化合物,以前尚未进行过探索。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号